Annual core operating profit increased in 2024 for British pharmaceutical company GSK compared to 2023, the company reported ...

Q4 2024Management ViewCEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over ...

Shares of GSK Plc. were gaining around 6 percent on the London Stock Exchange, as well as in the pre-market activity on the NYSE, ...

The pharmaceutical company said promising pipeline developments and high demand for drugs in its specialty segment lifted ...

European shares were slightly lower on Wednesday as tech stocks declined, offsetting gains in the healthcare and financial sectors.

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

GSK's business development team have been working overtime of late, with three R&D deals announced in the last few days across Alzheimer's disease and cancer. The Alzheimer's agreement – with ...

Teva Pharmaceutical Industries Ltd. ADR-0.62% $20.28B ...

DelveInsight's Peptide-drug Conjugate Market Insights report provides the current and forecast market analysis, individual ...

After hours: February 3 at 6:25:46 p.m. EST ...

Even as economic growth was just taking off, some economists were already pessimistic. Coal, wrote William Stanley Jevons in 1865, is “the mainspring of modern material civilisation”. Yet it ...